Clinical Trial Update: Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma [Phase 2]

View source ↗

Summary

Phase IIa safety and light-dose escalation trial in patients with primary or recurrent high-grade glioma using the Litx System to define the zone of tumor destr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Glioblastoma Multiforme
• Glioma

Drugs mentioned

• Litx System

Snippet

Sponsor: Light Sciences Oncology | Conditions: Glioma, Glioblastoma Multiforme | Phase 2 | Status: COMPLETED